Ned M. Weinshenker

JSK Therapeutics, Inc. develops anti-cancer drugs. It develops novel anti-cancer drugs using an approved compound to inhibit the growth of cancer cells. The company was founded by Thomas Kennedy and Paul J. Shami in 2008 and is headquartered in Salt Lake City, UT.

iVeena Delivery Systems, Inc. engages in the manufacture of eye drops. It develops ocular drug products that eliminate the need to apply eye drops and painful injections. The company was founded by Balamurali Ambati and is headquartered in Salt Lake, UT.

Veritract, Inc. engages in the development of feeding tubes with integrated optics and steering allowing precision tube placement and confirmation in the GI tract. The company was founded by John C. Fang in 2010 and is headquartered in Salt Lake City, UT.

Altea Therapeutics Corp. develops pharmaceutical products. It offers PassPort patch, a skin patch that uses short bursts of focused thermal energy to create tiny channels in the surface of the skin and these channels permit the flow of proteins, peptides, carbohydrates, and small molecules into the body without the use of needles. The firm also provides Transdermal vaccine patch, a delivery system for water-soluble drugs and proteins; disease prevention products; insulin skin patch, a non-injectable daily insulin product; and opioid patches that provide delivery of opioids and incorporates the layers of deterrents. The company was founded by Jonathan A Eppstein and Deborah Eppstein in 1998 and is headquartered in Atlanta, GA.